A Standardized Dataset of a Spontaneous Adverse Event Reporting System [PDF]
One of the largest spontaneous adverse events reporting databases in the world is the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS). Unfortunately, researchers face many obstacles in analyzing data from the FAERS database. One
M. A. Khaleel+4 more
semanticscholar +3 more sources
Adverse event reporting systems and safer healthcare [PDF]
At the heart of improvement and safety in healthcare is the now-familiar tenet that was espoused decades ago by Demming and paraphrased by Berwick.1 Need we repeat it again? Every defect should lead to improvement processes that make care safer. It is time to deliver on the promise of reporting systems in patient safety.
James B Battles, David Stevens
openalex +4 more sources
Military Healthcare Providers Reporting of Adverse Events Following Immunizations to the Vaccine Adverse Event Reporting System [PDF]
We studied military health care provider (HCP) practices regarding reporting of adverse events following immunization (AEFI).A convenience sample of HCP was surveyed to assess familiarity with Vaccine Adverse Event Reporting System (VAERS), AEFI they were likely to report, methods used and preferred for reporting, and perceived barriers to reporting ...
Rongxia Li+7 more
openalex +3 more sources
Assessing taxane-associated adverse events using the FDA adverse event reporting system database
. Background:. Taxanes are an essential class of antineoplastic agents used to treat various cancers and are a fundamental cause of hypersensitivity reactions. In addition, other adverse events, such as bone marrow toxicity and peripheral neuropathy, can
Dong-Hui Lao+4 more
doaj +3 more sources
Ocular Complications after COVID-19 Vaccination, Vaccine Adverse Event Reporting System
In December 2020, the U.S. Food and Drug Administration licensed COVID-19 vaccines for emergency use authorization. We investigated the ocular adverse event reports in patients reported to the Vaccine Adverse Event Reporting System (VAERS) following ...
Cyril N. A. Nyankerh+2 more
doaj +2 more sources
BackgroundFaricimab is the first and only bispecific antibody approved by the U.S. Food and Drug Administration (FDA) for intravitreal injection. Given its increasingly widespread use in retinal vascular diseases, understanding its adverse events (AEs ...
Chang-Zhu He+5 more
doaj +3 more sources
Safety assessment of gemtuzumab ozogamicin: real-world adverse event analysis based on the FDA Adverse Event Reporting System [PDF]
ObjectiveTo mine adverse drug events (ADEs) following the use of gemtuzumab ozogamicin based on the FDA Adverse Event Reporting System (FAERS), and to provide references for the safety assessment of clinical drug use.MethodsWe obtained reports of adverse
Xuexue Liu+10 more
doaj +2 more sources
Status and Problems of Adverse Event Reporting Systems in Korean Hospitals [PDF]
ObjectivesThis study identifies the current status and problems of adverse event reporting system in Korean hospitals. The data obtained from this study will be used to raise international awareness and enable collaborative researches on patient safety ...
Jeongeun Kim+3 more
doaj +5 more sources
Cyclobenzaprine-related adverse events: a comprehensive pharmacovigilance analysis using the FDA Adverse Event Reporting System [PDF]
BackgroundCyclobenzaprine, a centrally-acting muscle relaxant, is widely used for the treatment of musculoskeletal pain. Despite its efficacy, concerns regarding its safety profile, particularly adverse events (AEs), have been increasingly reported. This
Jiakuan Tu+6 more
doaj +2 more sources
Pharmacovigilance of drug-induced cataract using the FDA Adverse Event Reporting System [PDF]
Cataract is a leading cause of irreversible vision loss, particularly among the elderly, with drug-induced cataract being an underrecognized yet significant contributor to visual impairment.
Si-Yuan Hong+4 more
doaj +2 more sources